GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » Cyclically Adjusted Revenue per Share

American Oriental Bioengineering (American Oriental Bioengineering) Cyclically Adjusted Revenue per Share : $0.00 (As of Sep. 2013)


View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

American Oriental Bioengineering's adjusted revenue per share for the three months ended in Sep. 2013 was $245.699. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2013.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-25), American Oriental Bioengineering's current stock price is $0.0005. American Oriental Bioengineering's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2013 was $0.00. American Oriental Bioengineering's Cyclically Adjusted PS Ratio of today is .


American Oriental Bioengineering Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for American Oriental Bioengineering's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering Cyclically Adjusted Revenue per Share Chart

American Oriental Bioengineering Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

American Oriental Bioengineering Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of American Oriental Bioengineering's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, American Oriental Bioengineering's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Oriental Bioengineering's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Oriental Bioengineering's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where American Oriental Bioengineering's Cyclically Adjusted PS Ratio falls into.



American Oriental Bioengineering Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, American Oriental Bioengineering's adjusted Revenue per Share data for the three months ended in Sep. 2013 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2013 (Change)*Current CPI (Sep. 2013)
=245.699/97.3319*97.3319
=245.699

Current CPI (Sep. 2013) = 97.3319.

American Oriental Bioengineering Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200312 147.829 72.808 197.622
200403 179.000 73.682 236.453
200406 181.939 73.459 241.067
200409 216.853 74.637 282.791
200412 352.333 74.488 460.389
200503 224.488 75.597 289.031
200506 283.381 74.618 369.645
200509 304.705 75.290 393.910
200512 387.647 75.666 498.644
200603 312.902 76.340 398.946
200606 361.302 76.034 462.508
200609 429.762 76.413 547.413
200612 629.908 77.793 788.118
200703 389.742 78.884 480.889
200706 513.833 79.357 630.216
200709 580.187 81.276 694.806
200712 736.154 82.911 864.196
200803 497.038 85.485 565.921
200806 756.538 85.058 865.712
200809 830.518 85.057 950.369
200812 1,106.563 83.956 1,282.867
200903 529.621 84.457 610.357
200906 800.247 83.615 931.525
200909 885.607 84.369 1,021.673
200912 1,111.478 85.386 1,266.977
201003 603.933 86.316 681.007
201006 1,017.053 85.886 1,152.589
201009 1,204.382 87.267 1,343.284
201012 1,096.908 89.289 1,195.709
201103 684.237 91.154 730.612
201106 711.211 91.612 755.615
201109 709.671 92.711 745.042
201112 702.693 92.885 736.331
201203 325.886 94.367 336.126
201206 351.885 93.495 366.325
201209 388.066 94.482 399.771
201212 843.432 95.237 861.988
201303 287.767 96.372 290.634
201306 277.041 95.984 280.931
201309 245.699 97.332 245.699

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


American Oriental Bioengineering  (OTCPK:AOBI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


American Oriental Bioengineering Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oriental Bioengineering (American Oriental Bioengineering) Business Description

Traded in Other Exchanges
N/A
Address
1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176
Website
American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.
Executives
Patti Cosimo J director AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering (American Oriental Bioengineering) Headlines

No Headlines